Abstract:The design and development of contrast agents for magnetic resonance imaging (MRI) with improved chemical stability and higher contrasting capability for clinical translation compared to conventional contrast agents are still of great interest. In this study, a facile and universal approach was explored for controllable functionalization of red-emissive carbon nanodots (RCNDs) with diethylenetriaminepentaacetic anhydride (DTPA) for chelation of gadolinium. A series of accurate characterizations were used to control each step of the synthesis. The functionalization did not alter the band gap of the carbon nanodots, preserving their inherent far-red fluorescence. The as-prepared RCND-DTPA-Gd displayed a high colloidal stability with negligible Gd leakage. The nanodots also showed a better magnetic resonance relaxivity than commercial MRI agents. RCND-DTPA-Gd had good biocompatibility <i>in vivo</i> even at high doses. The systemically injected RCND-DTPA-Gd were found to be efficiently excreted through the renal route, a feature that further minimizes the potential toxicity risks. All these properties suggest that carbon nanodots can be well designed as efficient carriers of Gd, resulting in potential clinical tools as dual MRI/fluorescence functional probes for imaging applications. The approach described here could pave the pathway to a flexible strategy for the controllable functionalization of small-sized nanoparticles including carbon dots, rendering them more versatile. This work is expected to promote the future translation of carbon nanodots into clinical trials.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acsanm.0c02993?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsanm.0c02993</a>.Organ distribution of RCND-DTPA-Gd in vivo (Videos S1 and S2) (<a class="ext-link" href="/doi/suppl/10.1021/acsanm.0c02993/suppl_file/an0c02993_si_001.zip">ZIP</a>)Synthesis of DTPA ligand (Scheme S1), additional HAADF-STEM images of the RCND-DTPA-Gd sample (Figure S1), DLS of RCND-DTPA-Gd (Figure S2), FL spectra of CND-DTPA-Gd (Figure S3), cell viability of RCND-DTPA-Gd (Figure S4), and the hematological and biochemical parameters of RCND-DTPA (Tables S1 and S2) (<a class="ext-link" href="/doi/suppl/10.1021/acsanm.0c02993/suppl_file/an0c02993_si_002.pdf">PDF</a>)This article has not yet been cited by other publications.

A smart T(1)-weighted MRI contrast agent for uranyl cations based on a DNAzyme-gadolinium conjugate.

A Smart Magnetic Resonance Imaging Contrast Agent Responsive to Adenosine Based on a DNA Aptamer-Conjugated Gadolinium Complex.

Geometrical Confinement of Gadolinium Oxide Nanoparticles in Poly(ethylene Glycol)/arginylglycylaspartic Acid-Modified Mesoporous Carbon Nanospheres As an Enhanced T1 Magnetic Resonance Imaging Contrast Agent.

The Development of Dendritic Gd-Dtpa Complexes for Mri Contrast Agents

Gadolinium(III) Chelated Conjugated Polymer As a Potential MRI Contrast Agent

Gadolinium (III)-Chelated Deformable Mesoporous Organosilica Nanoparticles as Magnetic Resonance Imaging Contrast Agent.

A Dendritic Supramolecular Complex as Uniform Hybrid Micelle with Dual Structure for Bimodal In Vivo Imaging.

A Dendritic Supramolecular Complex As Uniform Hybrid Micelle with Dual Structure for Bimodal in Vivo Imaging

Cuins2/Zns Quantum Dots Conjugating Gd(Iii) Chelates for Near-Infrared Fluorescence and Magnetic Resonance Bimodal Imaging

Controlled Self-Assembling Of Gadolinium Nanoparticles As Smart Molecular Magnetic Resonance Imaging Contrast Agents

Single-Atom Gadolinium Nano-Contrast Agents with High Stability for Tumor <i>T</i><sub>1</sub> Magnetic Resonance Imaging

Single-Atom Gadolinium Nano-Contrast Agents with High Stability for Tumor T 1 Magnetic Resonance Imaging

Biodegradable Nanoglobular Magnetic Resonance Imaging Contrast Agent Constructed with Host-Guest Self-Assembly for Tumor-Targeted Imaging.

Gd-Dots with Strong Ligand-Water Interaction for Ultrasensitive Magnetic Resonance Renography

Target-switchable Gd(III)-DOTA/protein cage nanoparticle conjugates with multiple targeting affibody molecules as target selective T1 contrast agents for high-field MRI

Biochemical characterization of a uranyl ion-specific DNAzyme.

Gadolinium-Incorporated Carbon Nanodots for T 1 -Weighted Magnetic Resonance Imaging

Controlled intracellular self-assembly of gadolinium nanoparticles as smart molecular MR contrast agents

Stimuli-Responsive Biodegradable Hyperbranched Polymer–Gadolinium Conjugates as Efficient and Biocompatible Nanoscale Magnetic Resonance Imaging Contrast Agents

Dysprosium-Modified Gold Nanoparticles As T2ex Contrast Agents for Magnetic Resonance Imaging

Structure-Relaxivity Mechanism of an Ultrasmall Ferrite Nanoparticle T1 MR Contrast Agent: the Impact of Dopants Controlled Crystalline Core and Surface Disordered Shell.